J. Humphreys

发表

Patient perceptions of glucocorticoid side effects: a cross-sectional survey of users in an online health community

W. Dixon, J. McBeth, R. Costello, 2017, BMJ Open.

The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis

J. Humphreys, C. Holroyd, R. Seth, 2018, Rheumatology.

Mortality Trends in Patients With Early Rheumatoid Arthritis Over 20 Years: Results From the Norfolk Arthritis Register

M. Lunt, J. Humphreys, A. Warner, 2014, Arthritis care & research.

The incidence of rheumatoid arthritis in the UK: comparisons using the 2010 ACR/EULAR classification criteria and the 1987 ACR classification criteria. Results from the Norfolk Arthritis Register

D. Symmons, J. Humphreys, K. Hyrich, 2012, Annals of the rheumatic diseases.

Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate

W. Dixon, M. Lunt, R. Costello, 2017, Annals of the rheumatic diseases.

Association of Morbid Obesity With Disability in Early Inflammatory Polyarthritis: Results From the Norfolk Arthritis Register

I. Bruce, M. Lunt, J. Humphreys, 2013, Arthritis care & research.

The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis-Executive summary.

J. Humphreys, C. Holroyd, R. Seth, 2018, Rheumatology.

Basic science232. Certolizumab pegol prevents pro-inflammatory alterations in endothelial cell function

H. L. Wright, R. Moots, T. Spector, 2012 .

Rheumatoid factor and anti-citrullinated protein antibody positivity, but not level, are associated with increased mortality in patients with rheumatoid arthritis: results from two large independent cohorts

D. Symmons, J. Humphreys, J. Chipping, 2014, Arthritis Research & Therapy.

Validation of the 2010 American College of Rheumatology/ European League Against Rheumatism classification criteria for rheumatoid arthritis with special emphasis on the role of autoantibodies

J. Humphreys, 2015 .

What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis?

D. Symmons, J. Humphreys, K. Hyrich, 2016, Arthritis Research & Therapy.

The burden of musculoskeletal disease

J. Humphreys, S. Verstappen, 2021, Medicine.

Does body mass index mediate the relationship between socioeconomic position and incident osteoarthritis?

R. Cooper, J. Humphreys, S. Verstappen, 2022, Seminars in arthritis and rheumatism.

Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts

T. Huizinga, L. Trouw, S. Ajeganova, 2016, Annals of the rheumatic diseases.

How Do We Classify Rheumatoid Arthritis in Established Disease — Can We Apply the 2010 American College of Rheumatology/European League Against Rheumatism Classification Criteria?

J. Humphreys, T. Uhlig, T. Sokka, 2014, The Journal of Rheumatology.

Postpublication validation of the 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: where do we stand?

D. Symmons, J. Humphreys, 2013, Current opinion in rheumatology.

2010 ACR/EULAR classification criteria for rheumatoid arthritis predict increased mortality in patients with early arthritis: results from the Norfolk Arthritis Register.

D. Symmons, J. Humphreys, K. Hyrich, 2013, Rheumatology.

Incidence and prevalence of juvenile idiopathic arthritis in the United Kingdom, 2000–2018: results from the Clinical Practice Research Datalink

J. McDonagh, R. Costello, J. Humphreys, 2021, Rheumatology.

Validation studies of rheumatoid arthritis patient-reported outcome measures in populations at risk for inequity: A systematic review and analysis using the OMERACT summary of measurement properties equity table.

Christie M. Bartels, J. Petkovic, D. Beaton, 2022, Seminars in arthritis and rheumatism.

The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis.

J. Humphreys, C. Holroyd, R. Seth, 2018, Rheumatology.

Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

W. Dixon, R. Costello, J. Humphreys, 2020, Annals of the Rheumatic Diseases.

Timing of glucocorticoid administration: a cross-sectional survey of glucocorticoid users in an online social network for health

W. Dixon, R. Costello, Rikesh Patel, 2016, Rheumatology.

The impact of lifestyle behaviours, physical activity and smoking on morbidity and mortality in patients with rheumatoid arthritis.

J. Humphreys, S. Verstappen, J. Gwinnutt, 2020, Best practice & research. Clinical rheumatology.

Association of chemokine CXC ligand 12 gene polymorphism (rs1746048) with cardiovascular mortality in patients with rheumatoid arthritis: results from the Norfolk Arthritis Register

A. Barton, D. Symmons, S. Viatte, 2015, Annals of the rheumatic diseases.

Early-life predictors of future multi-morbidity: results from the Hertfordshire Cohort

C. Cooper, E. Dennison, J. Humphreys, 2018, Age and ageing.

Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study

D. Symmons, C. Terao, T. Huizinga, 2016, Arthritis Research & Therapy.

Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance

I. Bruce, G. Simons, J. Veldwijk, 2022, RMD Open.

The effect of glucocorticoid therapy on mortality in patients with rheumatoid arthritis and concomitant type II diabetes: a retrospective cohort study

W. Dixon, R. Emsley, M. Lunt, 2020, BMC Rheumatology.

Do associations between education and obesity vary depending on the measure of obesity used? A systematic literature review and meta-analysis

R. Cooper, J. Humphreys, S. Verstappen, 2021, SSM - population health.

Continuing specialist care into adulthood in young people with juvenile idiopathic arthritis: a retrospective cohort study using electronic health records in England

J. McDonagh, R. Costello, J. Humphreys, 2022, Rheumatology (Oxford, England).

Is the relationship between deprivation and outcomes in rheumatoid arthritis mediated by body mass index? A longitudinal cohort study

S. Hider, M. Lee, N. Viner, 2022, Rheumatology.

OP0123 SYMPTOMS IN FIRST DEGREE RELATIVES OF PATIENTS WITH RHEUMATOID ARTHRITIS: EVALUATION OF DATA FROM THE SYMPTOMS IN PERSONS AT RISK OF RHEUMATOID ARTHRITISQUESTIONNAIRE

I. Bruce, M. Haris, J. Sergeant, 2019, Oral Presentations.

Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register

D. Symmons, R. Toes, L. Trouw, 2015, Annals of the rheumatic diseases.

Association of anti-carbamylated protein antibodies with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register

D. Symmons, L. Trouw, B. Fu, 2015, The Lancet.

Continuing specialist care into adulthood in young people with juvenile idiopathic arthritis: a retrospective cohort study using electronic health records in England

J. McDonagh, R. Costello, J. Humphreys, 2022, Rheumatology.

P042 Using a Genetic PROBability tool (G-PROB) to aid diagnosis of patients with inflammatory arthritis: results from the Norfolk Arthritis Register

J. Bowes, C. F. Yap, S. Viatte, 2023, Rheumatology.